Skip to content
DefDex

Federal award

ADVANCED PHARMA, INC.

W81K0017P0269

Contract

Obligated and Ceiling

Obligated (net)
$146,768.30
Ceiling (potential value, not spending)
$146,768.30
Current value
$146,768.30
Gross positive obligations
$146,768.30

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ADVANCED PHARMA, INC. · NM67FH1QEPP8
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ADVANCED PHARMA, INC. · NM67FH1QEPP8
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
PIID
W81K0017P0269
Award type code
B
Actions
1 · Mar 14, 2017 to Mar 14, 2017
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
Mar 14, 2017FY20170—$146,768.30
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.